About Us:

3D’s current focus is on the dental marketplace, which is the first market for which a commercial product based on its technology has been developed.  Within the dentistry market, the company’s primary focus is on achieving wide-scale adoption of the CarieScan PRO^tm by dental practitioners in the USA and Canada in the first instance.  The directors believe that the best way to achieve market penetration is by entering into distribution agreements with suitably qualified local partners.

3D’s ultimate objective is to develop, market and commercialise a series of products through independent subsidiary companies based on its technology with a range of different applications, such as the early detection of osteoporosis, or of malignant melanomas, the state of health monitoring of battery systems for electric vehicles or early detection of corrosion within building materials.